David Preiss

Dr. David Preiss is an Honorary Clinical Senior Lecturer at the University of Glasgow's School of Cardiovascular & Metabolic Health. He specializes in cardiovascular disease, diabetes, and metabolic disorders, focusing on pharmacological interventions and biomarker research. His work examines therapies like statins, GLP-1 agonists, and SGLT2 inhibitors, particularly their effects on cardiovascular outcomes, diabetes progression, and kidney disease.

Key research interests include the mechanistic links between metabolic dysfunction and cardiovascular risks, with a focus on biomarkers (e.g., troponins, GDF15) for risk stratification. He has led studies like the CAMERA trial, investigating metformin in non-diabetic heart patients. Preiss frequently collaborates on systematic reviews, meta-analyses, and clinical trials addressing lipid-lowering therapies, diabetes management, and heart failure outcomes.

His contributions span over 90 peer-reviewed publications, emphasizing evidence-based approaches to cardiometabolic care. Collaborations with institutions like the BHF Glasgow Cardiovascular Research Centre highlight his translational research focus.